BGI will use Covaris’ LE220 parallel processing, multi-sample platform to fragment DNA samples for next-generation sequencing.
Covaris claims its AFA technology improves recoveries, increases efficiency, and provides high-quality reproducible DNA shearing results.
Wu of BGI said the Covaris LE220 instrument offers both high-throughput capability and high-quality results for their downstream applications.
Covaris president and CEO Jim Laugharn said the Covaris systems set the standard for advancing analytical technologies and sophisticated assays.
"Isothermal Covaris processes will be beneficial for proteomic-related studies such as ChIP," Laugharn said.
